ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
22/09/2023
Voltar para busca
Dado oficial do USPTO
HITMAB
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
32
Atualização mais recente
22/09/2023
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 42
Data de depósito
26/04/2021
Data de registro
27/09/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/09/2022
Última transação
27/09/2022
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
CN
Examinador
HUSSAIN, TASNEEM
Unidade examinadora
M90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Zhuhai Trinomab Pharmaceutical Co., Ltd.
TRINOMAB BIOTECH CO., LTD
Representantes
Scot A. Duvall Middleton Reutlinger
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Vaccines; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposes; pharmaceutical preparations for the prevention and treatment of HIV/AIDS; pharmaceutical preparations for the prevention and treatment of liver diseases; pharmaceutical preparations for the prevention and treatment of respiratory system disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseasesbacteria-based diseasesdiabetes; pharmaceutical preparations for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; drugs for medical purposes for the prevention and treatment of HIV/AIDS; drugs for medical purposes for the prevention and treatment of liver diseases; drugs for medical purposes for the prevention and treatment of respiratory system disorders; drugs for medical purposes for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases and diabetes; drugs for medical purposes for the prevention and treatment of gastro-intestinal diseases; drugs for medical purposes for the prevention and treatment of immune system related diseases and disorders; drugs for medical purposes for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; biological preparations for medical purposes for the prevention and treatment of HIV/AIDS; biological preparations for medical purposes for the prevention and treatment of liver diseases; biological preparations for medical purposes for the prevention and treatment of respiratory system disorders; biological preparations for medical purposes for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases and diabetes; biological preparations for medical purposes for the prevention and treatment of gastro-intestinal diseases; biological preparations for medical purposes for the prevention and treatment of immune system related diseases and disorders; biological preparations for medical purposes for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; medicines for human purposes for the prevention and treatment of HIV/ AIDS; medicines for human purposes for the prevention and treatment of liver diseases; medicines for human purposes for the prevention and treatment of respiratory system disorders; medicines for human purposes for the prevention and treatment of ocular disorders or diseasesbacteria-based diseases and diabetes; medicines for human purposes for the prevention and treatment of gastro-intestinal diseases; medicines for human purposes for the prevention and treatment of immune system related diseases and disorders; medicines for human purposes for the prevention and treatment of viral and infectious diseasesblood disorderspaininflammationsepsisalopeciaobesitycancertumors and cognitive disorders; chemico-pharmaceutical preparations for the treatment of viral and infectious diseasesimmune system related diseasescancertumors and inflammation; chemical preparations for pharmaceutical purposes for the treatment of viral and infectious diseasesimmune system related diseasescancertumors and inflammation
Classe 35
Retail store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceuticalveterinary and sanitary preparations and medical supplies
Classe 42
Biological research; research and development of new products for others; scientific laboratory services; scientific research; chemical analysis; conducting clinical trials for others; technological research in the fields of medicinethe preventiontreatment and management of illnesshealth care delivery; technological research in the fields of geneticsgenetic engineeringmolecular biology and cellular immunology; conducting technical scientific feasibility project studies; chemistry servicesconsultationresearch and advice; chemical research
Publicações
Histórico de despachos e eventos da marca no USPTO.
32 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/02/2023
FICS
FINAL DISPOSITION NOTICE SENT TO IB
18/01/2023
FIMP
FINAL DISPOSITION PROCESSED
18/01/2023
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
27/12/2022
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
27/09/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
27/09/2022
GPNX
NOTIFICATION PROCESSED BY IB
18/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/07/2022
PUBO
PUBLISHED FOR OPPOSITION
12/07/2022
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/06/2022
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/06/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/06/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
06/06/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/06/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
06/06/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/06/2022
DMCC
DATA MODIFICATION COMPLETED
03/06/2022
ALIE
ASSIGNED TO LIE
03/06/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
25/05/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/05/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/05/2022
RFNT
REFUSAL PROCESSED BY IB
06/02/2022
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
18/01/2022
RFRR
REFUSAL PROCESSED BY MPU
18/01/2022
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/12/2021
CNRT
NON-FINAL ACTION WRITTEN
27/12/2021
DOCK
ASSIGNED TO EXAMINER
22/12/2021
MAFR
APPLICATION FILING RECEIPT MAILED
27/07/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/07/2021
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
22/07/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace HITMAB ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.